Filed in archive
Corporate and Industrial News
by ruth on January 22, 2007

Biotech companies issue press releases all the time touting the potential of their experimental drugs, and the stocks move as a result.
But how do you separate the truth from the hype? What sort of questions should you be asking yourself when you evaluate these press releases? And where can you find the unbiased information you need?
Adam Feuerstein offers valuable insights in interpreting press releases, taking Point Therapeutics' press release as a case in point.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/50515
Mr Wong
Vote for Evaluating Press Releases Before Buying Biotech Stocks:
|
Rating: 7.00 out of 1 vote(s) cast.
|
Response from:
KT
(01/22/07 12:59pm)
I think you have an excellent, well articulated point in your article
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







